Component

RRR-alpha-tocopherol

The 2R,4′R,8′R stereoisomer of free alpha-tocopherol; distinct from acetate esters and all-rac mixtures. Natural alpha-tocopherol stereoisomer; esterified supplement forms are recorded separately.

19 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Vitamin E did not significantly improve fibrosis scores in PIVENS (P=0.24 versus placebo).

    RRR-alpha-tocopherol → Hepatic fibrosis score source_derived_draftungraded
    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes
    exposure
    RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83.
    limitations
    Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The liver-biopsy benefit did not establish fibrosis reversal.
    primary_references
    [e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929
    tissue_or_cell_type
    Liver biopsy

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1414–1425

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes · source_derived_draft · unverified_draft

    ### e-clin-pivens-fibrosis Vitamin E did not significantly improve fibrosis scores in PIVENS (P=0.24 versus placebo). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The liver-biopsy benefit did not establish fibrosis reversal. organism: Homo sapiens tissue_or_cell_type: Liver biopsy experimental_model: PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes limitations: Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit. exposure: RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83. cross_nutrient: false [e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929
    Complete structured claim and evidence
  2. PIVENS met its histological improvement endpoint in 43% of vitamin E recipients versus 19% of placebo recipients (P=0.001).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes
    exposure
    RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83.
    limitations
    Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes.
    primary_references
    [e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929
    tissue_or_cell_type
    Liver biopsy

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1401–1412

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes · source_derived_draft · unverified_draft

    ### e-clin-pivens-histology PIVENS met its histological improvement endpoint in 43% of vitamin E recipients versus 19% of placebo recipients (P=0.001). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The studied vitamin E treatment improved a defined liver-biopsy outcome in adults with NASH without diabetes. organism: Homo sapiens tissue_or_cell_type: Liver biopsy experimental_model: PIVENS randomized double-blind trial; 247 adults with biopsy-confirmed NASH without diabetes limitations: Histological endpoints in a defined nondiabetic NASH population, not proof of general liver benefit, fibrosis reversal, cirrhosis prevention or long-term survival benefit. exposure: RRR-alpha-tocopherol 800 IU/day for 96 weeks; E group n=84, placebo n=83. cross_nutrient: false [e-clin-pivens2010] Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010). https://pubmed.ncbi.nlm.nih.gov/20427778/ DOI: 10.1056/nejmoa0907929
    Complete structured claim and evidence
  3. TONIC did not meet its primary sustained-ALT endpoint with vitamin E: 15/58 children (26%) responded versus 10/58 (17%) with placebo (P=0.26).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD
    exposure
    RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each.
    limitations
    Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The pediatric trial did not achieve its primary liver-enzyme outcome.
    primary_references
    [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    tissue_or_cell_type
    Liver enzymes and biopsy

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1427–1438

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD · source_derived_draft · unverified_draft

    ### e-clin-tonic-alt TONIC did not meet its primary sustained-ALT endpoint with vitamin E: 15/58 children (26%) responded versus 10/58 (17%) with placebo (P=0.26). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The pediatric trial did not achieve its primary liver-enzyme outcome. organism: Homo sapiens tissue_or_cell_type: Liver enzymes and biopsy experimental_model: TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD limitations: Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome. exposure: RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each. cross_nutrient: false [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    Complete structured claim and evidence
  4. Among children with NASH in TONIC, resolution at 96 weeks occurred in 25/43 (58%) receiving vitamin E versus 11/39 (28%) receiving placebo (P=0.006).

    RRR-alpha-tocopherol → Steatohepatitis resolution source_derived_draftungraded
    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD
    exposure
    RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each.
    limitations
    Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    A secondary biopsy outcome improved even though the primary enzyme outcome did not.
    primary_references
    [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    tissue_or_cell_type
    Liver enzymes and biopsy

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1440–1451

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD · source_derived_draft · unverified_draft

    ### e-clin-tonic-histology Among children with NASH in TONIC, resolution at 96 weeks occurred in 25/43 (58%) receiving vitamin E versus 11/39 (28%) receiving placebo (P=0.006). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: A secondary biopsy outcome improved even though the primary enzyme outcome did not. organism: Homo sapiens tissue_or_cell_type: Liver enzymes and biopsy experimental_model: TONIC randomized double-blind trial; 173 children aged 8–17 with biopsy-confirmed NAFLD limitations: Primary sustained-ALT endpoint and secondary histology must remain distinct. Not evidence for every child, every liver condition or long-term clinical outcome. exposure: RRR-alpha-tocopherol 400 IU twice daily for 96 weeks; E and placebo groups n=58 each. cross_nutrient: false [e-clin-tonic2011] Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011). https://pubmed.ncbi.nlm.nih.gov/21521847/ DOI: 10.1001/jama.2011.520
    Complete structured claim and evidence
  5. Plasma phylloquinone and percentage undercarboxylated osteocalcin did not change significantly with vitamin E supplementation despite increased PIVKA-II.

    RRR-alpha-tocopherol → Undercarboxylated osteocalcin source_derived_draftungraded
    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men
    exposure
    RRR-alpha-tocopherol 1000 IU/day; participants were not receiving oral anticoagulant therapy.
    limitations
    Biochemical marker study, not a bleeding-events trial. The study does not identify CYP4F2 activation, direct GGCX inhibition or clinical vitamin K deficiency as the causal route.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The vitamin K-related markers did not all respond in the same way.
    primary_references
    [e-clin-booth2004] Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. (2004). https://pubmed.ncbi.nlm.nih.gov/15213041/ DOI: 10.1093/ajcn/80.1.143
    tissue_or_cell_type
    Circulation and vitamin K-dependent carboxylation

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1271–1282

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men · source_derived_draft · unverified_draft

    ### e-clin-vitamin-k-marker-boundary Plasma phylloquinone and percentage undercarboxylated osteocalcin did not change significantly with vitamin E supplementation despite increased PIVKA-II. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The vitamin K-related markers did not all respond in the same way. organism: Homo sapiens tissue_or_cell_type: Circulation and vitamin K-dependent carboxylation experimental_model: Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men limitations: Biochemical marker study, not a bleeding-events trial. The study does not identify CYP4F2 activation, direct GGCX inhibition or clinical vitamin K deficiency as the causal route. exposure: RRR-alpha-tocopherol 1000 IU/day; participants were not receiving oral anticoagulant therapy. cross_nutrient: true [e-clin-booth2004] Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. (2004). https://pubmed.ncbi.nlm.nih.gov/15213041/ DOI: 10.1093/ajcn/80.1.143
    Complete structured claim and evidence
  6. High-dose RRR-alpha-tocopherol increased PIVKA-II in both 12-week adult trials: mean values rose from 1.7 to 11.9 ng/mL and from 1.8 to 5.3 ng/mL.

    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men
    exposure
    RRR-alpha-tocopherol 1000 IU/day; participants were not receiving oral anticoagulant therapy.
    limitations
    Biochemical marker study, not a bleeding-events trial. The study does not identify CYP4F2 activation, direct GGCX inhibition or clinical vitamin K deficiency as the causal route.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    High-dose vitamin E altered a vitamin K-dependent clotting-protein marker.
    primary_references
    [e-clin-booth2004] Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. (2004). https://pubmed.ncbi.nlm.nih.gov/15213041/ DOI: 10.1093/ajcn/80.1.143
    tissue_or_cell_type
    Circulation and vitamin K-dependent carboxylation

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 1258–1269

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men · source_derived_draft · unverified_draft

    ### e-clin-vitamin-k-pivka High-dose RRR-alpha-tocopherol increased PIVKA-II in both 12-week adult trials: mean values rose from 1.7 to 11.9 ng/mL and from 1.8 to 5.3 ng/mL. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: High-dose vitamin E altered a vitamin K-dependent clotting-protein marker. organism: Homo sapiens tissue_or_cell_type: Circulation and vitamin K-dependent carboxylation experimental_model: Two independent 12-week randomized trials; 38 adults with rheumatoid arthritis and 32 healthy men limitations: Biochemical marker study, not a bleeding-events trial. The study does not identify CYP4F2 activation, direct GGCX inhibition or clinical vitamin K deficiency as the causal route. exposure: RRR-alpha-tocopherol 1000 IU/day; participants were not receiving oral anticoagulant therapy. cross_nutrient: true [e-clin-booth2004] Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status. (2004). https://pubmed.ncbi.nlm.nih.gov/15213041/ DOI: 10.1093/ajcn/80.1.143
    Complete structured claim and evidence
  7. RRR-alpha-tocopherol at 0.1–10 µM inhibited cofactor-dependent recombinant human PKC alpha activity in phosphatidylserine-containing assays.

    RRR-alpha-tocopherol → Protein kinase C alpha (PRKCA) source_derived_draftungraded
    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Recombinant HIS-tagged human PKC alpha biochemical assay
    exposure
    15 ng PKC alpha; 2 mM CaCl2; phosphatidylserine 15–60 µg/mL; 5 min pretreatment, 30 min kinase assay.
    limitations
    Effect depends on reconstituted lipid composition and activation mode; it is not a clinical dosing claim.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    Natural alpha-tocopherol reduced PKC alpha activity in a purified system containing its lipid and calcium cofactors.
    primary_references
    [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    tissue_or_cell_type
    Cell-free enzyme

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 933–944

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant HIS-tagged human PKC alpha biochemical assay · source_derived_draft · unverified_draft

    ### e-sig-alpha-pkc-cofactor RRR-alpha-tocopherol at 0.1–10 µM inhibited cofactor-dependent recombinant human PKC alpha activity in phosphatidylserine-containing assays. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Natural alpha-tocopherol reduced PKC alpha activity in a purified system containing its lipid and calcium cofactors. organism: Homo sapiens tissue_or_cell_type: Cell-free enzyme experimental_model: Recombinant HIS-tagged human PKC alpha biochemical assay limitations: Effect depends on reconstituted lipid composition and activation mode; it is not a clinical dosing claim. exposure: 15 ng PKC alpha; 2 mM CaCl2; phosphatidylserine 15–60 µg/mL; 5 min pretreatment, 30 min kinase assay. cross_nutrient: true [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    Complete structured claim and evidence
  8. RRR-alpha-tocopherol at 0.01 µM inhibited peroxide/iron-induced activation of recombinant PKC alpha; gamma-tocopherol required 0.1 µM for significant inhibition in the same assay.

    RRR-alpha-tocopherol → Protein kinase C alpha (PRKCA) source_derived_draftungraded
    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Recombinant HIS-tagged human PKC alpha biochemical assay with iron and peroxide
    exposure
    15 ng dialyzed PKC alpha; 45 µM FeCl2; 1 or 10 mM H2O2 activation for 2 min, stopped with 9 mM DTT; no PS or calcium cofactors.
    limitations
    Millimolar peroxide in a cell-free reaction is not normal intracellular exposure. This is distinct from cofactor-dependent gamma activation.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    Both natural tocopherols reduced oxidative activation of this kinase, with alpha active at a lower tested concentration.
    primary_references
    [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    tissue_or_cell_type
    Cell-free enzyme

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 959–970

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant HIS-tagged human PKC alpha biochemical assay with iron and peroxide · source_derived_draft · unverified_draft

    ### e-sig-alpha-pkc-oxidative RRR-alpha-tocopherol at 0.01 µM inhibited peroxide/iron-induced activation of recombinant PKC alpha; gamma-tocopherol required 0.1 µM for significant inhibition in the same assay. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Both natural tocopherols reduced oxidative activation of this kinase, with alpha active at a lower tested concentration. organism: Homo sapiens tissue_or_cell_type: Cell-free enzyme experimental_model: Recombinant HIS-tagged human PKC alpha biochemical assay with iron and peroxide limitations: Millimolar peroxide in a cell-free reaction is not normal intracellular exposure. This is distinct from cofactor-dependent gamma activation. exposure: 15 ng dialyzed PKC alpha; 45 µM FeCl2; 1 or 10 mM H2O2 activation for 2 min, stopped with 9 mM DTT; no PS or calcium cofactors. cross_nutrient: true [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    Complete structured claim and evidence
  9. Adding 1 mol% alpha-tocopherol enhanced isolated PKC alpha C2-domain association with phosphatidylserine-containing lipid surfaces by surface plasmon resonance. Tocopherol without phosphatidylserine did not support binding.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Surface plasmon resonance with recombinant C2 domain and lipid vesicles
    exposure
    Base lipid composition 70:20:10 mol%; alpha-tocopherol at 1 mol% replacing POPC; no-PS control had 10 mol% tocopherol.
    limitations
    A membrane association endpoint is distinct from kinase activation. No direct C2-domain binding to free tocopherol is claimed.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Recombinant construct; species not independently stated
    plain_language
    Alpha-tocopherol changed how the kinase’s membrane-binding domain associated with a membrane containing phosphatidylserine.
    primary_references
    [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    tissue_or_cell_type
    Artificial POPC/POPE/POPS membrane

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 998–1009

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Surface plasmon resonance with recombinant C2 domain and lipid vesicles · source_derived_draft · unverified_draft

    ### e-sig-alpha-pkc-ps-association Adding 1 mol% alpha-tocopherol enhanced isolated PKC alpha C2-domain association with phosphatidylserine-containing lipid surfaces by surface plasmon resonance. Tocopherol without phosphatidylserine did not support binding. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Alpha-tocopherol changed how the kinase’s membrane-binding domain associated with a membrane containing phosphatidylserine. organism: Recombinant construct; species not independently stated tissue_or_cell_type: Artificial POPC/POPE/POPS membrane experimental_model: Surface plasmon resonance with recombinant C2 domain and lipid vesicles limitations: A membrane association endpoint is distinct from kinase activation. No direct C2-domain binding to free tocopherol is claimed. exposure: Base lipid composition 70:20:10 mol%; alpha-tocopherol at 1 mol% replacing POPC; no-PS control had 10 mol% tocopherol. cross_nutrient: false [mccary2012] Vitamin E isoforms directly bind PKCα and differentially regulate activation of PKCα. (2012). https://pubmed.ncbi.nlm.nih.gov/21933153/ DOI: 10.1042/bj20111318
    Complete structured claim and evidence
  10. Alpha-tocopherol did not increase phylloquinone omega-hydroxylation in CYP4F2 microsomes; the study reported a slight decrease in apparent phylloquinone Vmax.

    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Recombinant human CYP4F2 co-substrate kinetics
    exposure
    Labeled phylloquinone 0–50 µM with RRR-alpha-tocopherol 0–50 µM or SRR-alpha-tocopherol 0–100 µM; 30 min, 37 °C, 1 mM NADPH.
    limitations
    Does not exclude other mechanisms of vitamin E–K interaction in animals or humans.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Human protein in insect microsomes
    plain_language
    This assay did not support faster vitamin K1 breakdown caused by alpha-tocopherol.
    primary_references
    [farley2013] ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol. (2013). https://pubmed.ncbi.nlm.nih.gov/23650179/ DOI: 10.1002/mnfr.201200797
    tissue_or_cell_type
    Microsomal enzyme preparation

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 467–478

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Recombinant human CYP4F2 co-substrate kinetics · source_derived_draft · unverified_draft

    ### ve-transport-alpha-does-not-activate-k1-catabolism Alpha-tocopherol did not increase phylloquinone omega-hydroxylation in CYP4F2 microsomes; the study reported a slight decrease in apparent phylloquinone Vmax. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: This assay did not support faster vitamin K1 breakdown caused by alpha-tocopherol. organism: Human protein in insect microsomes tissue_or_cell_type: Microsomal enzyme preparation experimental_model: Recombinant human CYP4F2 co-substrate kinetics limitations: Does not exclude other mechanisms of vitamin E–K interaction in animals or humans. exposure: Labeled phylloquinone 0–50 µM with RRR-alpha-tocopherol 0–50 µM or SRR-alpha-tocopherol 0–100 µM; 30 min, 37 °C, 1 mM NADPH. cross_nutrient: true [farley2013] ω-Hydroxylation of phylloquinone by CYP4F2 is not increased by α-tocopherol. (2013). https://pubmed.ncbi.nlm.nih.gov/23650179/ DOI: 10.1002/mnfr.201200797
    Complete structured claim and evidence
  11. After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, the human chylomicron fraction contained similar concentrations of the two tocopherol stereoisomers.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Human stable-isotope oral study with lipoprotein fractionation
    exposure
    Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours.
    limitations
    Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    Early chylomicron delivery did not strongly distinguish the two tested stereoisomers.
    primary_references
    [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    tissue_or_cell_type
    Plasma chylomicron or VLDL fractions

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 298–309

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human stable-isotope oral study with lipoprotein fractionation · source_derived_draft · unverified_draft

    ### ve-transport-chylomicron-stereoisomers After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, the human chylomicron fraction contained similar concentrations of the two tocopherol stereoisomers. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Early chylomicron delivery did not strongly distinguish the two tested stereoisomers. organism: Homo sapiens tissue_or_cell_type: Plasma chylomicron or VLDL fractions experimental_model: Human stable-isotope oral study with lipoprotein fractionation limitations: Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit. exposure: Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours. cross_nutrient: false [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    Complete structured claim and evidence
  12. Adding alpha-tocopherol to vitamin E-depleted rat hepatoma cells expressing human TTP changed its punctate perinuclear distribution to a diffuse cellular pattern.

    Experimental context and source evidence
    availability_state
    nutrient_deficiency Imported condition classification; unverified.
    cross_nutrient
    false
    experimental_model
    Human TTP expressed in depleted McARH7777 cells; Figure 2A
    exposure
    More than 10 passages in alpha-tocopherol-free defined serum; 35 µM serum-complexed d-alpha-tocopherol for 24 hours.
    limitations
    Depletion/repletion model with overexpressed human protein; localization is not a clinical deficiency threshold.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Rattus norvegicus cells; Homo sapiens protein
    plain_language
    Vitamin E supply changed where its transfer protein accumulated in these cells.
    primary_references
    [chung2016] Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein. (2016). https://pubmed.ncbi.nlm.nih.gov/27307040/ DOI: 10.1074/jbc.m116.734210
    tissue_or_cell_type
    Hepatoma cells
    trigger_kind
    nutrient_deficiency Imported condition classification; unverified.

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 337–348

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human TTP expressed in depleted McARH7777 cells; Figure 2A · source_derived_draft · unverified_draft

    ### ve-transport-depletion-repletion-ttp-localization Adding alpha-tocopherol to vitamin E-depleted rat hepatoma cells expressing human TTP changed its punctate perinuclear distribution to a diffuse cellular pattern. Condition category: nutrient_deficiency nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin E supply changed where its transfer protein accumulated in these cells. organism: Rattus norvegicus cells; Homo sapiens protein tissue_or_cell_type: Hepatoma cells experimental_model: Human TTP expressed in depleted McARH7777 cells; Figure 2A limitations: Depletion/repletion model with overexpressed human protein; localization is not a clinical deficiency threshold. exposure: More than 10 passages in alpha-tocopherol-free defined serum; 35 µM serum-complexed d-alpha-tocopherol for 24 hours. cross_nutrient: false [chung2016] Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein. (2016). https://pubmed.ncbi.nlm.nih.gov/27307040/ DOI: 10.1074/jbc.m116.734210
    Complete structured claim and evidence
  13. After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, human VLDL became enriched in RRR-alpha-tocopherol relative to SRR-alpha-tocopherol by 11 hours.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Human stable-isotope oral study with lipoprotein fractionation
    exposure
    Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours.
    limitations
    Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    A later lipoprotein fraction favored the RRR form.
    primary_references
    [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    tissue_or_cell_type
    Plasma chylomicron or VLDL fractions

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 311–322

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human stable-isotope oral study with lipoprotein fractionation · source_derived_draft · unverified_draft

    ### ve-transport-vldl-stereoisomers After equal oral labeled RRR- and SRR-alpha-tocopheryl acetate, human VLDL became enriched in RRR-alpha-tocopherol relative to SRR-alpha-tocopherol by 11 hours. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: A later lipoprotein fraction favored the RRR form. organism: Homo sapiens tissue_or_cell_type: Plasma chylomicron or VLDL fractions experimental_model: Human stable-isotope oral study with lipoprotein fractionation limitations: Small tracer study; fraction enrichment alone does not prove the molecular sorting step or clinical benefit. exposure: Four subjects received equal paired doses of labeled RRR and SRR acetate ester with breakfast: 40, 50, 75 or 75 mg of each ester; samples through 76 hours. cross_nutrient: false [traber1990] RRR- and SRR-alpha-tocopherols are secreted without discrimination in human chylomicrons, but RRR-alpha-tocopherol is preferentially secreted in very low density lipoproteins. (1990). https://pubmed.ncbi.nlm.nih.gov/2351872/ DOI: 10.1016/s0022-2275(20)42836-6
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Human TTP(R221W) remained punctate after alpha-tocopherol treatment in rat McARH7777 cells, unlike wild-type TTP.

    Experimental context and source evidence
    availability_state
    machinery_impairment Imported condition classification; unverified.
    cross_nutrient
    false
    experimental_model
    Human wild-type versus R221W TTP expression; Figure 2B
    exposure
    35 µM serum-complexed alpha-tocopherol for 24 hours after medium depletion.
    limitations
    Mutation contrast is machinery impairment; this does not establish that supplementation cannot help AVED clinically.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Human proteins in Rattus norvegicus cells
    plain_language
    An AVED-associated variant failed to change location when vitamin E was supplied.
    primary_references
    [chung2016] Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein. (2016). https://pubmed.ncbi.nlm.nih.gov/27307040/ DOI: 10.1074/jbc.m116.734210
    tissue_or_cell_type
    Hepatoma cells
    trigger_kind
    machinery_impairment Imported condition classification; unverified.

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 350–361

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human wild-type versus R221W TTP expression; Figure 2B · source_derived_draft · unverified_draft

    ### ve-transport-r221w-localization Human TTP(R221W) remained punctate after alpha-tocopherol treatment in rat McARH7777 cells, unlike wild-type TTP. Condition category: machinery_impairment nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: An AVED-associated variant failed to change location when vitamin E was supplied. organism: Human proteins in Rattus norvegicus cells tissue_or_cell_type: Hepatoma cells experimental_model: Human wild-type versus R221W TTP expression; Figure 2B limitations: Mutation contrast is machinery impairment; this does not establish that supplementation cannot help AVED clinically. exposure: 35 µM serum-complexed alpha-tocopherol for 24 hours after medium depletion. cross_nutrient: false [chung2016] Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein. (2016). https://pubmed.ncbi.nlm.nih.gov/27307040/ DOI: 10.1074/jbc.m116.734210
    Complete structured claim and evidence
  2. In a rat alpha-TTP membrane-transfer competition assay, alpha-tocotrienol had relative affinity 12.4% of RRR-alpha-tocopherol (100%).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Purified rat liver protein and membrane-transfer competition
    exposure
    37 °C, 30 min; Table 1 competition-derived affinity.
    limitations
    Relative transfer competition, not a direct Kd or human clinical efficacy ratio.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Rattus norvegicus
    plain_language
    Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol.
    primary_references
    [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    tissue_or_cell_type
    Liver protein/liposomes

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 168–179

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver protein and membrane-transfer competition · source_derived_draft · unverified_draft

    ### ve-transport-rat-ttp-affinity-alpha-tocotrienol In a rat alpha-TTP membrane-transfer competition assay, alpha-tocotrienol had relative affinity 12.4% of RRR-alpha-tocopherol (100%). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol. organism: Rattus norvegicus tissue_or_cell_type: Liver protein/liposomes experimental_model: Purified rat liver protein and membrane-transfer competition limitations: Relative transfer competition, not a direct Kd or human clinical efficacy ratio. exposure: 37 °C, 30 min; Table 1 competition-derived affinity. cross_nutrient: false [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    Complete structured claim and evidence
  3. In a rat alpha-TTP membrane-transfer competition assay, gamma-tocopherol had relative affinity 8.9% of RRR-alpha-tocopherol (100%).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Purified rat liver protein and membrane-transfer competition
    exposure
    37 °C, 30 min; Table 1 competition-derived affinity.
    limitations
    Relative transfer competition, not a direct Kd or human clinical efficacy ratio.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Rattus norvegicus
    plain_language
    Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol.
    primary_references
    [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    tissue_or_cell_type
    Liver protein/liposomes

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 155–166

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver protein and membrane-transfer competition · source_derived_draft · unverified_draft

    ### ve-transport-rat-ttp-affinity-gamma-tocopherol In a rat alpha-TTP membrane-transfer competition assay, gamma-tocopherol had relative affinity 8.9% of RRR-alpha-tocopherol (100%). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol. organism: Rattus norvegicus tissue_or_cell_type: Liver protein/liposomes experimental_model: Purified rat liver protein and membrane-transfer competition limitations: Relative transfer competition, not a direct Kd or human clinical efficacy ratio. exposure: 37 °C, 30 min; Table 1 competition-derived affinity. cross_nutrient: false [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    Complete structured claim and evidence
  4. In a rat alpha-TTP membrane-transfer competition assay, SRR-alpha-tocopherol had relative affinity 10.5% of RRR-alpha-tocopherol (100%).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Purified rat liver protein and membrane-transfer competition
    exposure
    37 °C, 30 min; Table 1 competition-derived affinity.
    limitations
    Relative transfer competition, not a direct Kd or human clinical efficacy ratio.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Rattus norvegicus
    plain_language
    Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol.
    primary_references
    [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    tissue_or_cell_type
    Liver protein/liposomes

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 142–153

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified rat liver protein and membrane-transfer competition · source_derived_draft · unverified_draft

    ### ve-transport-rat-ttp-affinity-srr-alpha-tocopherol In a rat alpha-TTP membrane-transfer competition assay, SRR-alpha-tocopherol had relative affinity 10.5% of RRR-alpha-tocopherol (100%). Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: Rat alpha-TTP distinguished this form from RRR-alpha-tocopherol. organism: Rattus norvegicus tissue_or_cell_type: Liver protein/liposomes experimental_model: Purified rat liver protein and membrane-transfer competition limitations: Relative transfer competition, not a direct Kd or human clinical efficacy ratio. exposure: 37 °C, 30 min; Table 1 competition-derived affinity. cross_nutrient: false [hosomi1997] Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs. (1997). https://pubmed.ncbi.nlm.nih.gov/9199513/ DOI: 10.1016/s0014-5793(97)00499-7
    Complete structured claim and evidence
  5. SR-BI antibody or BLT1 reduced RRR-alpha-tocopherol efflux from loaded Caco-2 TC7 cells into apical vitamin-free mixed micelles.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Preloaded Caco-2 TC7 monolayers
    exposure
    Tocopherol-preloaded cells; apical acceptor micelles; time-course Figure 4.
    limitations
    Apical return is distinct from basolateral secretion; acceptor availability affects the result.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    The same receptor also helped vitamin E leave toward the gut-facing side.
    primary_references
    [reboul2006] Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. (2006). https://pubmed.ncbi.nlm.nih.gov/16380385/ DOI: 10.1074/jbc.m509042200
    tissue_or_cell_type
    Intestinal epithelial cell model

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 194–205

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Preloaded Caco-2 TC7 monolayers · source_derived_draft · unverified_draft

    ### ve-transport-scarb1-apical-efflux SR-BI antibody or BLT1 reduced RRR-alpha-tocopherol efflux from loaded Caco-2 TC7 cells into apical vitamin-free mixed micelles. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: The same receptor also helped vitamin E leave toward the gut-facing side. organism: Homo sapiens tissue_or_cell_type: Intestinal epithelial cell model experimental_model: Preloaded Caco-2 TC7 monolayers limitations: Apical return is distinct from basolateral secretion; acceptor availability affects the result. exposure: Tocopherol-preloaded cells; apical acceptor micelles; time-course Figure 4. cross_nutrient: false [reboul2006] Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. (2006). https://pubmed.ncbi.nlm.nih.gov/16380385/ DOI: 10.1074/jbc.m509042200
    Complete structured claim and evidence
  6. Blocking SR-BI with an extracellular antibody or BLT1 reduced RRR-alpha-tocopherol uptake by human Caco-2 TC7 cells.

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Differentiated Caco-2 TC7 monolayers
    exposure
    60-min pretreatment: antibody 3.75 µg/mL or BLT1 10 µM; 40 µM micellar RRR-alpha-tocopherol for 60 min.
    limitations
    Inhibitor/antibody evidence; contribution under these conditions is not the sole absorption route.
    nutrient_topic
    Vitamin E research collection; topical membership is not evidence of a direct dietary effect. · Vitamin E
    organism
    Homo sapiens
    plain_language
    SR-BI helped these intestinal cells take up vitamin E.
    primary_references
    [reboul2006] Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. (2006). https://pubmed.ncbi.nlm.nih.gov/16380385/ DOI: 10.1074/jbc.m509042200
    tissue_or_cell_type
    Intestinal epithelial cell model

    Vitamin E: transport, membrane protection and nutrient interactions (2026-09-17) · lines 181–192

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Differentiated Caco-2 TC7 monolayers · source_derived_draft · unverified_draft

    ### ve-transport-scarb1-uptake Blocking SR-BI with an extracellular antibody or BLT1 reduced RRR-alpha-tocopherol uptake by human Caco-2 TC7 cells. Condition category: normal nutrient_topic: Vitamin E research collection; topical membership is not evidence of a direct dietary effect. plain_language: SR-BI helped these intestinal cells take up vitamin E. organism: Homo sapiens tissue_or_cell_type: Intestinal epithelial cell model experimental_model: Differentiated Caco-2 TC7 monolayers limitations: Inhibitor/antibody evidence; contribution under these conditions is not the sole absorption route. exposure: 60-min pretreatment: antibody 3.75 µg/mL or BLT1 10 µM; 40 µM micellar RRR-alpha-tocopherol for 60 min. cross_nutrient: false [reboul2006] Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the enterocyte. (2006). https://pubmed.ncbi.nlm.nih.gov/16380385/ DOI: 10.1074/jbc.m509042200
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards